100 related articles for article (PubMed ID: 16328051)
1. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan.
Chen SC; Lin CY; Chen YH; Fang HY; Cheng CY; Chang CW; Chen RA; Tai HL; Lee CH; Chou MC; Lin TS; Hsu LS
Oncol Rep; 2006 Jan; 15(1):167-72. PubMed ID: 16328051
[TBL] [Abstract][Full Text] [Related]
2. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
Hsu LS; Lee HC; Chau GY; Yin PH; Chi CW; Lui WY
Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic and genetic alterations of the EDNRB gene in nasopharyngeal carcinoma.
Zhou L; Feng X; Shan W; Zhou W; Liu W; Wang L; Zhu B; Yi H; Yao K; Ren C
Oncology; 2007; 72(5-6):357-63. PubMed ID: 18187958
[TBL] [Abstract][Full Text] [Related]
4. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
[TBL] [Abstract][Full Text] [Related]
5. ANKRD18A as a novel epigenetic regulation gene in lung cancer.
Liu WB; Han F; Jiang X; Yang LJ; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Biochem Biophys Res Commun; 2012 Dec; 429(3-4):180-5. PubMed ID: 23131552
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of thyroid hormone receptor β1 gene expression in gastric cancer involves promoter methylation.
Ling Y; Shi X; Wang Y; Ling X; Li Q
Biochem Biophys Res Commun; 2014 Feb; 444(2):147-52. PubMed ID: 24434154
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation of p16 and EDNRB gene in leukemia patients in Taiwan.
Hsiao PC; Liu MC; Chen LM; Tsai CY; Wang YT; Chen J; Hsu LS
Chin J Physiol; 2008 Feb; 51(1):27-31. PubMed ID: 18551992
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
Chang HC; Cho CY; Hung WC
Cancer Sci; 2007 Feb; 98(2):169-73. PubMed ID: 17233834
[TBL] [Abstract][Full Text] [Related]
11. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic inactivation of Betaig-h3 gene in human cancer cells.
Shao G; Berenguer J; Borczuk AC; Powell CA; Hei TK; Zhao Y
Cancer Res; 2006 May; 66(9):4566-73. PubMed ID: 16651406
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
[TBL] [Abstract][Full Text] [Related]
14. The correlation between aberrant connexin 43 mRNA expression induced by promoter methylation and nodal micrometastasis in non-small cell lung cancer.
Chen JT; Cheng YW; Chou MC; Sen-Lin T; Lai WW; Ho WL; Lee H
Clin Cancer Res; 2003 Sep; 9(11):4200-4. PubMed ID: 14519646
[TBL] [Abstract][Full Text] [Related]
15. Gene promoter hypermethylation in mouse lung tumors.
Vuillemenot BR; Hutt JA; Belinsky SA
Mol Cancer Res; 2006 Apr; 4(4):267-73. PubMed ID: 16603640
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation-modulated down-regulation of CDH1 expression contributes to the progression of esophageal cancer.
Ling ZQ; Li P; Ge MH; Zhao X; Hu FJ; Fang XH; Dong ZM; Mao WM
Int J Mol Med; 2011 May; 27(5):625-35. PubMed ID: 21373750
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the GATA genes in lung cancer.
Guo M; Akiyama Y; House MG; Hooker CM; Heath E; Gabrielson E; Yang SC; Han Y; Baylin SB; Herman JG; Brock MV
Clin Cancer Res; 2004 Dec; 10(23):7917-24. PubMed ID: 15585625
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of RASSF1A in head and neck cancer.
Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151
[TBL] [Abstract][Full Text] [Related]
19. SOX10, in combination with Sp1, regulates the endothelin receptor type B gene in human melanocyte lineage cells.
Yokoyama S; Takeda K; Shibahara S
FEBS J; 2006 Apr; 273(8):1805-20. PubMed ID: 16623715
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of RASGRF2 and RASSF1A in human non-small cell lung cancer.
Chen H; Suzuki M; Nakamura Y; Ohira M; Ando S; Iida T; Nakajima T; Nakagawara A; Kimura H
Oncol Rep; 2006 May; 15(5):1281-5. PubMed ID: 16596198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]